EARS Auris Medical Holding Ag

Auris Medical Holding AG is a clinical-stage biopharmaceutical company. It is engaged in the development of novel products for the treatment of inner ear disorders. Its product candidate is AM-101.

As of 04/09/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Bermuda
Country of incorporation:  
IPO date:  08/06/2014
Outstanding shares:  12,869,587
Average volume:  4,462,976
Market cap:   $55,467,920
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    H03579101
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   3.31
PS ratio:   0.00
Return on equity:   -90.97%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy